Gelatin-based hydrogels promote chondrogenic differentiation of human adipose tissue-derived mesenchymal stem cells in vitro by Salamon, Achim et al.
Materials 2014, xx, 1-x; doi:10.3390/——
OPEN ACCESS
materials
ISSN 1996-1944
www.mdpi.com/journal/materials
Article
Gelatin-Based Hydrogels Promote Chondrogenic Differentiation
of Human Adipose Tissue-Derived Mesenchymal Stem Cells
In Vitro
Achim Salamon 1,†,∗, Sandra van Vlierberghe 2,†,∗, Ine van Nieuwenhove 2, Frank Baudisch 1,
Geert-Jan Graulus 2, Verena Benecke 1, Kristin Alberti 1, Hans-Georg Neumann 3,
Joachim Rychly 1, Jose´ C. Martins 4, Peter Dubruel 2 and Kirsten Peters 1
1 Department of Cell Biology, Rostock University Medical Center, Schillingallee 69, Rostock D-18057,
Germany; E-Mails: frank.baudisch@gmail.com (F.B.); verena.benecke@web.de (V.B.);
joachim.rychly@med.uni-rostock.de (J.R.); kirsten.peters@med.uni-rostock.de (K.P.)
2 Polymer Chemistry and Biomaterials Group, Gent University, Krijgslaan 281, Building S4,
Gent BE-9000, Belgium; E-Mails: ine.vannieuwenhove@ugent.be (I.N.);
geertjan.graulus@ugent.be (G.-J.G.); peter.dubruel@ugent.be (P.D.)
3 DOT GmbH, Charles-Darwin-Ring 1a, Rostock D-18059, Germany;
E-Mail: neumann@dot-coating.de
4 NMR and Structure Analysis Research Group, Gent University, Krijgslaan 281, Building S4,
Gent BE-9000, Belgium; E-Mail: jose.martins@ugent.be
† These authors contributed equally to this work.
* Authors to whom correspondence should be addressed;
E-Mails: achim.salamon@med.uni-rostock.de (A.S.) (stem cell part);
sandra.vanvlierberghe@ugent.be (S.V.) (hydrogel part).
Received: 20 December 2013; inrevised form: 24 January 2014 / Accepted: 27 January 2014 /
Published: xx
Abstract: Due to the weak regeneration potential of cartilage, there is a high clinical
incidence of articular joint disease, leading to a strong demand for cartilaginous tissue
surrogates. The aim of this study was to evaluate a gelatin-based hydrogel for its suitability
to support chondrogenic differentiation of human mesenchymal stem cells. Gelatin-based
hydrogels are biodegradable, show high biocompatibility, and offer possibilities to introduce
functional groups and/or ligands. In order to prove their chondrogenesis-supporting
potential, a hydrogel film was developed and compared with standard cell culture polystyrene
regarding the differentiation behavior of human mesenchymal stem cells. Cellular basis
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for this study were human adipose tissue-derived mesenchymal stem cells, which exhibit
differentiation potential along the adipogenic, osteogenic and chondrogenic lineage. The
results obtained show a promotive effect of gelatin-based hydrogels on chondrogenic
differentiation of mesenchymal stem cells in vitro and therefore encourage subsequent
in vivo studies.
Keywords: adipose tissue-derived mesenchymal stem cells (adMSC); gelatin-based
hydrogels; chondrogenic differentiation; tissue engineering
1. Introduction
Articular cartilage has only weak regeneration potential [1]. Following traumatic or degenerative
cartilage injury, this leads to a strong clinical demand for cartilaginous tissue surrogates. Since current
strategies of autologous chondrocyte implantation suffer from chondrocyte de-differentiation following
expansion in vitro [2], stem cells in conjunction with biomaterial scaffolds are quested to both accelerate
and improve cartilage tissue repair [3]. The aim of the present study was to evaluate a new approach
for cartilage tissue regeneration based on the utilization of mesenchymal stem cells (MSC) in contact to
biodegradable gelatin-based hydrogels as supporting matrix.
The main constituent of the hydrogels developed is gelatin, a non-toxic, biodegradable and water-
soluble protein derived from collagen, with the latter being a major component of mesenchymal tissue
extracellular matrix (ECM). Gelatin retains informational signals including an arginine-glycine-aspartic
acid (RGD) sequence, which promotes cell adhesion, proliferation and stem cell differentiation [4].
According to the production process, two types of gelatin with different isoelectric points can be
distinguished [5]. Via acidic hydrolysis of collagen, gelatin type A with an isoelectric point of 6 to
8 is obtained. Conversely, an alkaline collagen treatment results in the development of gelatin type
B with an isoelectric point of 4.7 to 5.3 [6]. In the present work, gelatin type B was selected as
starting material, exhibiting superior biocompatibility compared to gelatin type A due to the different
treatment conditions applied [7]. A characteristic property of gelatin is that it exhibits Upper Critical
Solution Temperature behavior (UCST). Above a specific temperature threshold of 40 ◦C, gelatin can be
dissolved in water by the formation of flexible, random single coils. Upon cooling, hydrogen bonding
and Van der Waals interactions occur, resulting in the formation of triple helices. These collagen-like
triple helices act as junction zones and thus trigger the sol-gel transition. However, in the scope of
tissue engineering applications, chemical crosslinks still need to be incorporated to ensure stability
around body temperature, as the physical crosslinks melt at these temperatures [8]. To date, several
crosslinking strategies have already been elaborated. For example, Van Vlierberghe et al.[8] applied thiol
functionalities that can be oxidized to disulfides in the presence of a suitable oxidant such as hydrogen
peroxide. However, as unprotected thiols are sensitive to crosslinking in the presence of oxygen,
hydrogel processing is not very straightforward in an air environment. Alternatively, a conventional
carbodiimide crosslinking strategy is often applied, combining 1-ethyl-3-(3-dimethylaminopropyl)
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carbodiimide (EDC) with N-hydroxysuccinimide (NHS) in order to covalently link the amines present
in gelatin with the activated carboxylic acids [9–11]. In the latter case however, the processed hydrogel
structure typically is incubated in a solution containing EDC and NHS. As a result, the crosslinking
kinetics are of utmost importance, as gelatin also swells in an aqueous environment. Furthermore,
genipin, a natural crosslinker extracted from gardenia fruit, has already been reported on as well with
respect to gelatin crosslinking, as it combines two primary amines functions [12]. Unfortunately, this
crosslinker typically requires longer crosslinking times. In the present work, gelatin was functionalized
with methacrylamide side groups, enabling the chemical crosslinking upon applying UV-irradiation
in the presence of a UV-active photo-initiator. The above-mentioned properties including its unique
gel-forming ability render gelatin an interesting biopolymer towards tissue engineering applications.
MSC are progenitor cells resident in specialized niches within mesenchymal tissues in vivo and
govern tissue regeneration by their intrinsic capacity for self-renewal and multipotent mesenchymal
differentiation [13,14]. MSC were discovered within the bone marrow stroma [15] as adventitial cells
on the outer surface of sinusoidal blood vessels [16]. Later on, the perivasculature was recognized
to be the characteristic niche of all MSC independent of their tissue origin [17]. In this study, we used
adipose tissue-derived MSC (adMSC). adMSC make up 7% of the cells found in liposuction-derived and
collagenase-digested adipose tissue [18] and being present at a concentration of roughly 50,000 cells per
ml tissue [19], which is 100-fold higher than that of bone marrow-derived MSC (bmMSC) [20]. Human
adMSC were shown to directly differentiate into osteoblasts and endothelial cells in a non-union fracture
model in SCID mice [20] and in immunodeficient rats [21]. In that manner, adMSC were demonstrated
to reconstitute bone physiology in mice [20], rats [21,22], pigs [23], and dogs [24]. In human case
studies, human adMSC were already successfully used to treat critical size calvarial [25] and maxilla
defects [26] that, due to the limitation in the amount of auto-graftable bone tissue, could otherwise not
have been healed. Finally, adMSC were demonstrated to engraft at long-term at the transplantation
site and to migrate to and survive within the perivascular MSC niche [20–22,27]. Therefore, adMSC
fulfill all MSC characteristics defined by the International Society for Cellular Therapy, the International
Federation of Adipose Therapeutics and Sciences, and others [28–30] and thus are a crucial cell type for
regenerative medicine.
2. Experimental Section
2.1. Preparation of Chemically Crosslinked Gelatin Hydrogels
Gelatin type B, isolated from bovine skin, was kindly supplied by Rousselot (Ghent, Belgium).
Gelatin samples with an approximate isoelectric point of 5 and a Bloom strength of 257 were used.
Methacrylic anhydride (MAA) was purchased from Aldrich (Bornem, Belgium) and was applied as
received. Dialysis membranes Spectra/Por 4 (MWCO 12,000 – 14,000 Da) were obtained from Polylab
(Antwerp, Belgium). 1-[4-(2-Hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-propane-1-one (Irgacure
2959) was a kind gift from Ciba Specialty Chemicals N.V. (Groot-Bijgaarden, Belgium). A LWUV-lamp
model VL-400L (Vilber Lourmat, Marne La Vallee, France) with an intensity of 10 mW/cm2 and a
wavelength range of 250 – 450 nm was applied in order to cure the hydrogels.
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Gelatin was dissolved in PBS buffer (pH 7.3) at 40 ◦C. While vigorously stirring, 1 equivalent
methacrylic anhydride relative to the amine functionalities present in gelatin B was added. After 1 h
reaction time, the methacrylamide-modified gelatin (gel-MOD, see reaction scheme below) was purified
via dialysis (MWCO: 12,000 – 14,000 Da), followed by freeze-drying. Interestingly, the amount of
crosslinkable side groups can be adjusted by varying the amount of methacrylic anhydride added. In
the present work, a modification degree of 60% was applied, which was obtained by the addition of one
equivalent methacrylic anhydride.
Scheme 1. Modification of gelatin with methacrylic anhydride.
2.2. Characterization of Gelatin-Based Hydrogels
2.2.1. HR-MAS Spectroscopy
High Resolution Magic Angle Spinning NMR spectroscopy (HR-MAS NMR) of the developed
hydrogel films was performed on a Bruker Avance II 700 spectrometer (700.13 MHz) using a HR-MAS
probe equipped with a 1H, 13C, 119Sn and gradient coil. The spinning rate was adjusted to 6 kHz.
HR-MAS samples were obtained by placing a small amount of the freeze-dried hydrogels inside a 4 mm
zirconium oxide MAS rotor (50 µL). A few microliter of deuterium oxide (D2O) were added to the rotor,
allowing the samples to swell. The samples were homogenized by manual stirring prior to analysis. A
teflon-coated cap was used to close the rotor.
2.2.2. X-ray Photoelectron Spectroscopy
X-ray photoelectron spectroscopy (XPS) was applied as a non-destructive, quantitative spectroscopic
technique to determine the chemical composition of native and functionalized gelatin. A FISONS
S-PROBE with a fine focus Al-Kα source (1486 eV) and a quartz monochromator developed by Fisons
Instruments Surface Science (now Sanofi, Paris, France) was used for the measurement performed using
a dedicated XPS instrument able to give the ultimate in performance, while providing a high sample
throughput. All measurements were done in triplicate in a vacuum of at least 10−9 Pa. Wide and
narrow-scan spectra were acquired at pass energies of 158 and 56 eV, respectively. The binding energy
was calibrated by the C1s peak at 284.6 eV, and the utilized spot size was 250 µm on 1 mm. Data
analysis was performed using S-PROBE software.
2.3. adMSC Isolation and Culture
If not stated otherwise, all plasticware was from Greiner Bio-One (Frickenhausen, Germany), whereas
all reagents were from Sigma-Aldrich (Taufkirchen, Germany).
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adMSC were isolated from adipose tissue of healthy patients having undergone tumescence-based
liposuction. As described previously [31], adipose tissue was digested using Collagenase NB4 (SERVA,
Heidelberg, Germany), a mixture of a neutral protease and the collagenases I and II (6 mg/mL in
phosphate-buffered saline (PBS); PAA Laboratories, Co¨lbe, Germany). The cells thus liberated from the
digested tissue were incubated over night under standard cell culture conditions (5% CO2 and 37 ◦C in a
humidified atmosphere). CD34+ adventitial cells were isolated from total plastic-adherent cells using an
antibody-magnetizable bead-based system (Life Technologies, Darmstadt, Germany) [32]. After three
passages, adMSC were seeded into experimentation at 20,000 cells per cm2. Expression of MSC markers
CD29, CD44, CD105, and CD166, and absence of CD14+/CD68+ monocytes/macrophages and CD31+
endothelial cells as well as absence of Mycoplasma species was confirmed.
The adMSC cultivation media used were unstimulated control medium (US) and chondrogenic
differentiation stimulating medium (CS). US was Dulbecco’s Modified Eagle Medium (DMEM), high
glucose, GlutaMAX-I, supplemented with 1% penicillin/streptomycin (100 U/mL and 100 µg/mL,
respectively; both Life Technologies), and 10% fetal calf serum (FCS; PAN Biotech, Aidenbach,
Germany). CS medium was serum-free US medium supplemented with 100 nM dexamethasone,
50 µg/mL ascorbic acid, 50 ng/mL insulin-like growth factor 1 (R&D Systems, Wiesbaden-Nordenstadt,
Germany), 50 ng/mL TGF beta 1 (PeproTech, Hamburg, Germany) and 5 µg/mL insulin, 5 µg/mL
transferrin and 5 ng/mL selenious acid (the latter three: BD Biosciences, Heidelberg, Germany).
At confluence, culture with distinct differentiation-inducing media began, termed day zero, and took
up to 28 d. Renewal of medium was every second to third day.
2.4. Ethical Statement
adMSC were isolated from patient tissue after written informed consent had been obtained that
patients are willing to participate in this study. The study was approved by the ethics committee
of Rostock University Medical Center (http://www.ethik.med.uni-rostock.de/) under the registration
numbers A17/2007 and A2013-0112, and it complies with the ethical standards defined by the World
Medical Association Declaration of Helsinki.
2.5. Analysis of adMSC Chondrogenic Differentiation
2.5.1. Live-Dead Staining of adMSC on Hydrogels
adMSC were seeded onto TCPS and hydrogels and cultured for four weeks in US and CS medium.
For live-dead staining, cells were incubated for 10 min under standard culture conditions with US
medium supplemented with 3 µM Hoechst 33342, 500 nM propidium iodide and 1 µM calcein
acetoxymethyl ester (calcein AM, from Life Technologies, Carlsbad, CA, USA). After medium exchange
for US medium, cells were subjected to fluorescence microscopy (Carl Zeiss MicroImaging, Go¨ttingen,
Germany) using the blue, green and red emission filters. Emission maxima of the dyes are 460 nm
(DAPI), 516 nm (calcein), and 617 nm (propidium iodide). Excitation maxima are 360 nm (DAPI), 496
nm (calcein), and 535 nm (propidium iodide).
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2.5.2. Quantification of Chondrogenic Marker Gene Expression
Gene expression analysis was done after 14 and 28 days of adMSC culture on TCPS and hydrogels
in US and CS medium, employing real-time reverse transcriptase polymerase chain reaction (real-time
RT PCR). Briefly, cells were homogenized by centrifugation on QIAshredder columns (Qiagen, Hilden,
Germany), and RNA was isolated from the lysate using the innuPREP RNA Mini Kit (Analytik Jena,
Jena, Germany) following the manufacturer’s instructions. Subsequently, RNA was transcribed into
cDNA using the QuantiTect Reverse Transcription Kit (Qiagen). Real-time PCR of transcribed samples
was then performed on a 7500 Real Time PCR system using the Power SYBR Green PCR Master Mix
(both Life Technologies). Expression of chondrogenic marker genes was determined using the primers
listed in Table 1:
Table 1. Sequences of primers used in real-time RT PCR.
Gene Accession Number Forward Primer (5’-3’) Reverse Primer (5’-3’)
ACTB NM 001101.2 cttcctgggcatggagtc agcactgtgttggcgtacag
SOX5 NM 178010.1 aagcctttcctgacatgcac tccagcgagatcccaatatc
SOX9 NM 000346.2 tgggcaagctctggagac cgttcttcaccgacttcctc
COL1A1 NM 000088.3 acgaagacatcccaccaatc agatcacgtcatcgcacaac
COL2A1 NM 033150.2 aatggtggcttccatttcag gtgatgttctgggagccttc
VEGFA NM 001025366.1 ccttgctgctctacctccac aatctgcatggtgatgttgg
Both cDNA-specific primers were designed using the Primer3 engine [33]. Gene expression levels
were determined by the ∆∆Ct method, normalizing to the expression of actin, beta (ACTB).
2.5.3. Staining of Cartilaginous Matrix Proteins
Acidic polysaccharides present in cartilage, which mostly are glycosaminoglycans, were stained after
28 days of adMSC culture using Alcian Blue, resulting in a greenish-blue staining of the extracellular
matrix. Briefly, cells were fixed with 4% paraformaldehyde for 1 h at room temperature, washed 3× in
2% acetic acid and incubated over night at room temperature in Alcian Blue staining solution (1 mg/mL
Alcian Blue 8 (pH = 2) mixed isovolumetrically with 80 mg/mL MgCl2, both in 0.9% NaCl). After
washing 3× with 2% acetic acid and 3× with double distilled water (ddH2O), cells were subjected to
bright-field phase contrast microscopy (Carl Zeiss MicroImaging).
2.6. Data Illustration and Statistics
Data are illustrated as box plots created using R [34]. Since the data obtained were in most cases not
normally distributed, testing for significance in the difference between two datasets was done using the
non-parametric Mann-Whitney U test. The level of significance was set to a p-value of lower or equal
0.05 (p ≤ 0.05) and determined using R.
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3. Results and Discussion
3.1. Hydrogel Physico-Chemical Characterization
Crosslinking of a 10% (w/v) gelatin-methacrylamide (gel-MOD) solution was done via
photo-initiation upon applying UV-irradiation in the presence of 2 mol% Irgacure 2959 (with respect
to the methacrylamide side chains present). The polymer solutions were injected between two parallel
glass plates separated by a 1 mm thick silicone spacer. The materials were allowed to form gels after
applying UV-A irradiation.
High Resolution Magic Angle Spinning Nuclear Magnetic Resonance (HR-MAS NMR) spectroscopy
was applied as a straightforward technique to evaluate the crosslinking efficiency of the UV-cured
hydrogels. Conventional 1H-NMR spectroscopy does not enable the characterization of water-insoluble
polymer networks due to considerable line broadening resulting from the presence of dipolar couplings
and magnetic susceptibility [35,36]. However, this broadening can be circumvented by rapidly rotating
(in the order of kilohertz) the sample at a magic angle θ of 54.7◦ with respect to the static magnetic
field [36]. In this way, the contribution of the line broadening effects defined by a (3 cos2 θ − 1)/2
orientation dependence is removed from the spectrum. Further decrease in line width is realized by
swelling the hydrogel samples in a suitable deuterated solvent resulting in sufficient, solution-like,
rotational mobility of the polymer [37]. As a consequence, highly crosslinked hydrogel materials
exhibiting a reduced chain mobility will show broader peaks than less crosslinked materials [38].
The crosslinking efficiency can be determined by comparing the integration of the signal
corresponding to the double bonds with the integration of a signal that remains chemically inert during
crosslinking. Upon crosslinking, the introduced double bonds are consumed, enabling determination
of the crosslinking efficiency (CE). The CE is calculated by comparing the intensity of the signals
characterizing the protons of the double bonds, before and after crosslinking. Since different samples
have to be compared, normalization is required using the inert signal (i.e., at 1.1 ppm). The crosslinking
efficiency for the cured gelatin hydrogels is given by the following formula [37], where the superscript i
stands for initial, non-crosslinked and c for crosslinked:
CE (%) =
 I
i
5.75 or 5.1 ppm
Ii1.1 ppm
− Ic5.75 or 5.51 ppm
Ic1.1 ppm
Ii5.75 or 5.51 ppm
Ii1.1 ppm
 · 100
HR-MAS spectroscopy indicated an efficient UV-crosslinking for the gelatin-based hydrogels as a
CE of 69% was obtained (see Figure 1).
In a subsequent part of the present work, the effect of the functionalization on the chemical
composition of gelatin was determined via XPS measurements. Table 2 shows an overview of the
atomic composition of gelatin and gel-MOD. The results indicate that Gel-MOD exhibits lower values
compared to gelatin for the N/C ratio (i.e., 0.12 versus 0.19) and the N/O ratio (i.e., 0.56 versus 0.72),
as anticipated based on the fact that methacrylamide moieties are introduced on the primary amines of
(hydroxy-)lysine upon modification. For each primary amine in the gelatin backbone that is converted
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into methacrylamide, three additional carbons and one additional oxygen are introduced (see reaction
scheme on page 4). The results therefore indicate that the gelatin modification was successful.
Figure 1. 1H-Nuclear Magnetic Resonance (NMR) spectrum of non-crosslinked
gelatin-methacrylamide (top) and High Resolution Magic Angle Spinning (HR-MAS) NMR
spectrum of crosslinked gelatin-methacrylamide (bottom).
Table 2. Atomic surface composition (in atomic %) of gelatin and methacrylamide-modified
gelatin (gel-MOD) obtained by means of X-ray photoelectron spectroscopy.
Element Gelatin (%) Gel-MOD (%)
C 69 72
N 13 10
O 18 18
N/C 0.19 0.12
N/O 0.72 0.56
3.2. adMSC Chondrogenic Differentiation on Hydrogels
3.2.1. Live-Dead Staining of adMSC on Hydrogels
For testing of cytocompatibility and phenotypical changes upon differentiation-inducing conditions,
human adMSC were live dead-stained following seeding onto hydrogels pre-incubated for 2 h with
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cell culture medium. Tissue culture polystyrene (TCPS) was used as a control adhesion surface. After
28 days of chondrogenic stimulation (CS) on TCPS, adMSC showed a more condensed and cobblestone-
like phenotype with distinct areas of cell aggregation, which was not the case for the unstimulated (US)
control adMSC being evenly spread and showing a spindle-like shape typical for cells of the fibroblastoid
lineage (Figure 2). On the hydrogels without chondrogenic stimulation, adMSC tended to aggregate,
but still showed a spindle-like phenotype, while chondrogenic stimulation of adMSC on the hydrogels
resulted in strong aggregation into spheroid-like structures of approximately 70 µm diameter.
Figure 2. Phenotype of adMSC on hydrogels after 28 days of chondrogenic stimulation.
adMSC were seeded onto hydrogels (HG) at 20,000 cells/cm2, tissue culture
polystyrene (TCPS) serving as a control. After cell attachment, medium was exchanged
and cells were grown to a confluent layer. At that point, chondrogenic stimulation (CS)
was started and done for 28 days, exchanging cell culture medium every second to third
day and using unsupplemented medium as unstimulated control (US). Live cell staining was
with calcein AM (green fluorescence), dead cell staining was with propidium iodide (red
fluorescence), and total cell nuclei staining was with Hoechst33342 (blue fluorescence).
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The cellular condensation step observed on the hydrogels after chondrogenic stimulation resembles
the process of mesenchymal condensation, i.e., the aggregation of cells into three-dimensional
structures that subsequently build up the distinct layers of cell-extracellular matrix composites
found in cartilaginous tissue [39,40]. Mesenchymal condensation is a prerequisite for chondrogenic
differentiation to occur [41–43] and depends on matrix elasticity. Human bmMSC on flexible silk
fibroin matrices with a lateral elasticity modulus of 4.8 GPa were found to maintain a rounded
cell phenotype, to promote cell aggregation in chondrogenic medium and to significantly increase
cartilaginous type II collagen and glycosaminoglycan accumulation as well as SOX9 expression, while
stiffer matrices of 7.8 GPa composed of identical material supported a flattened cell phenotype without
cellular aggregation and increased cartilage marker expression [44]. Thus, the gelatin-based hydrogels
used here promote adMSC condensation, but require additional chondrogenic stimulation to fully induce
this differentiation pathway.
3.2.2. Staining of Cartilaginous Matrix Proteins
Having noticed that chondrogenically stimulated adMSC aggregated into spheroid-like structures on
the hydrogels, we looked for the presence of acidic polysaccharides characteristic for cartilaginous
tissue, since cartilage extracellular matrix characteristically consists of proteins glycosylated by
glycosaminoglycans, so-called proteoglycans as e.g., aggrecan (ACAN) [2,42]. Staining of acidic
glycosaminoglycans on the surface and within the hydrogels was done using Alcian Blue [45,46].
Following Alcian Blue staining, we found a strong accumulation of glycosaminoglycans inside the
spheroids formed by chondrogenically stimulated adMSC on the hydrogels, while the even cell layer
formed by chondrogenically stimulated adMSC on TCPS showed negligible staining (Figure 3).
Figure 3. Acidic polysaccharide staining of chondrogenically stimulated adMSC on
hydrogels after 28 d of stimulation. Chondrogenically stimulated (CS) adMSC on
tissue culture polystyrene (TCPS) or on hydrogels (HG) were stained for the presence
of glycosaminoglycans using Alcian Blue and visualized by bright-field phase contrast
microscopy. The scale bar is 100 µm.
Thus, hydrogels, in combination with chondrogenic stimulants, have a strong inductive effect on the
deposition of cartilaginous matrix components by adMSC.
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3.2.3. Expression of Chondrogenic Marker Genes
To more closely and quantitatively investigate onset and progression of chondrogenic differentiation
of adMSC on the hydrogels, we analyzed expression of genes involved in that process using real-time
RT PCR. Expression of SOX9, a gene encoding a member of the SOX (SRY-related HMG-box) family,
was upregulated on hydrogels and following chondrogenic stimulation (Figure 4A). The strongest
SOX9 expression was found for chondrogenically stimulated adMSC on the hydrogels after 28 days.
Expression of the transcription factor SOX5 gene, another member of the HMG-box class DNA-binding
proteins, was significantly and time-dependently upregulated on the hydrogels as compared to TCPS
(Figure 4B). Upon chondrogenic stimulation of adMSC, expression of this gene significantly increased,
an effect that was the strongest on the hydrogels. (Please check the whole text, SOX should be italic or
not?)
The trio of SOX transcription factors 5, 6 and 9 plays a crucial role in chondrogenesis, SOX9 being
the mayor player and the single factor containing a transactivation domain, while complexation with
SOX5 and 6, which contain only DNA-binding domains, has a promotive effect on cooperative binding
of the homodimerized SOX trio to enhancers of chondrocyte-specific genes [47]. Moreover, SOX9
upregulates expression of SOX5 and SOX6 [43] and is required for chondrogenic lineage commitment
by MSC condensation, its expression shutting down at the prehypertrophic stage, while the auxiliary
SOX5 is expressed in a constitutive manner, being activated in prechondrocytes and highly expressed
until the chondroblast stage [41–43]. Chondrogenic stimulation using transforming growth factors beta
1 (TGFβ1) or 3 (TGFβ3) was shown to upregulate SOX9, while osteogenic stimulation via the Wingless
Int-1 pathway (WNT) downregulates this factor [43]. Simultaneously, SOX9 was reported to inhibit the
osteoblastogenesis key transcription factor runt-related transcription factor 2 (RUNX2) [40]. Therefore,
our chondrogenic transcription factor gene expression data underline a promotive impact of the hydrogels
on chondrogenic differentiation of adMSC in vitro.
This supportive impact of the hydrogels is sustained by the data obtained for collagen gene expression.
Cartilage consists primarily of type II collagen that entraps hydrated proteoglycans and glycoproteins
to build a gel-like extracellular matrix, and the SOX trio of transcription factors binds to a type II
collagen enhancer to directly drive expression of COL2A1, the gene encoding the alpha-1 chain of type II
collagen [41–43]. In our experiments, COL2A1 expression was significantly and time-dependently
upregulated for chondrogenically stimulated adMSC on the hydrogels, but downregulated on TCPS
(Figure 4C). Expression of COL1A1, the gene encoding the pro-alpha-1 chains of the fibril-forming
collagen type I found most connective tissues, was significantly upregulated upon chondrogenic
stimulation, an effect that was significantly stronger on the hydrogels (Figure 4D). Since most cartilage
in vivo is articular cartilage located in between joint space and bone and type I collagen is the mayor
collagen type found in bone [39,48], our gene expression data for type I and II collagen clearly point out
a promotive effect of the hydrogels on chondrogenic differentiation of adMSC in vitro.
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Figure 4. Analysis of chondrogenic marker gene expression by adMSC on hydrogels after
14 and 28 days of chondrogenic stimulation. Gene expression was analyzed by real-time RT
PCR, normalizing to the expression of the beta actin gene ACTB. We analyzed expression of
transcription factors sex determining region Y box 9 (SOX9) and 5 (SOX5) (subfigures (A)
and (B), respectively), collagen type II, alpha 1 (COL2A1) and type I, alpha 1 (COL1A1)
(subfigures (C) and (D), respectively), and vascular endothelial growth factor A (VEGFA)
(subfigure (E)). Mann-Whitney U test, p ≤ 0.05. * TCPS significantly different to HG, # US
significantly different to CS, + 14 days significantly different to 28 days.
Finally, we found expression of the VEGFA gene to be strongly upregulated for adMSC on the
hydrogels, but to be significantly downregulated when cells were stimulated chondrogenically (see
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Figure 4E). Vascular endothelial growth factor A (VEGFA) is a prominent player in vasculogenesis
whose expression is induced by SOX9 [49] and COL2A1 [50], but most interestingly by the
hypoxia-induced transcription factor hypoxia inducible factor 1 alpha (HIF1A), as shown in rat PC12
cells [51], in human pulmonary artery endothelial cells [52] and in human Hep3B cells [53]. Within the
avascular and alymphatic cartilaginous tissue [1], HIF1A was shown to be required for endochondral
ossification to proceed [39], being a critical survival factor for hypoxic chondrocytes and increasing
cartilaginous extracellular matrix accumulation and early chondrogenesis [50]. Thus, the strong
upregulation of VEGFA expression for unstimulated adMSC on the hydrogels may reflect the onset of
gene expression to counteract hypoxic conditions occurring in the center of the spheroids formed, while
additionally stimulating chondrogenically abolishes pro-angiogenic gene expression despite central
hypoxia and therefore resembles chondrogenesis in vivo.
4. Conclusions
Hence, our gene and protein expression data argue in favor of a pro-chondrogenic impact of
gelatin-based hydrogels on adMSC in vitro. Data on chondrogenic differentiation of MSC on
gelatin-based hydrogels are rare in the literature [8]. Commonly used naturally-derived hydrogels in
cartilage studies are based on collagen and alginate [48] or on hydroxyapatite [1]. In these studies,
stronger cartilaginous extracellular matrix synthesis and a more physiologic compressibility were
observed. However, proteoglycan content was only 10% of that present in the nucleus pulposus of
intervertebral discs in vivo, which leaves a great need for improvement. Initial studies employing
rabbit bmMSC on an osteochondral composite material consisting of a polyethylen glycol and a gelatin
microparticles layer promisingly were found to differentiate into osteoblasts or chondrocytes in the
respective layer, TGFβ1 supplementation of the gelatin layer and presence of osteoblastic cells in the
polyethylen glycol layer both having a supportive effect on chondrogenesis [54]. Moreover, the inductive
effect our hydrogels have on spontaneous adMSC spheroid formation are likely to promote chondrogenic
differentiation, since rat bmMSC embedded in gelatin hydrogel microspheres releasing TGFβ1 were
found to more strongly produce glycosaminoglycans than bmMSC on gelatin sheets [55]. Therefore, the
gelatin-based hydrogels we produced are promising candidates for subsequent in vivo studies aiming at
disease-state cartilage regeneration.
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